No effect of Trp64Arg β3-adrenoceptor polymorphism on the plasma leptin concentration in Pima Indians

被引:4
|
作者
Snitker, S
Nicolson, M
Shuldiner, AR
Silver, K
Ravussin, E
机构
[1] NIDDK, Clin Diabet & Nutr Sect, NIH, Phoenix, AZ 85016 USA
[2] Univ Maryland, Baltimore, MD 21201 USA
[3] Amgen, Thousand Oaks, CA USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1998年 / 47卷 / 12期
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0026-0495(98)90081-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In rodents, administration of leptin promotes beta(3)-adrenergic stimulation of thermogenesis in brown adipose tissue. Conversely, administration of a beta(3)-adrenoceptor (beta(3)-AR) agonist decreases leptin mRNA expression and secretion, suggesting that leptin and sympathetic nervous system activity mediated through the beta(3)-AR comprise a negative-feedback loop. It has recently been proposed that a defect in the beta(3)-AR in humans may contribute to a resistance to the sympathetically mediated effects of leptin on thermogenesis and lipolysis, thus leading to obesity and type 2 diabetes mellitus. We thus hypothesized that the Trp64Arg variant in the human beta(3)-AR would be associated with elevated plasma leptin concentrations. We studied 101 healthy nondiabetic Pima Indians: 11 Arg64 homozygotes, 35 Trp64 homozygotes. and 55 heterozygotes. The fasting plasma leptin concentration as an absolute value or after adjustment for percent body fat and sex was not associated with the beta(3)-AR genotype. Thus, the data do not support an influence of the Trp64Arg variant on the plasma leptin concentration. Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:1525 / 1527
页数:3
相关论文
共 50 条
  • [1] No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue
    S. Snitker
    O. E. Odeleye
    J. Hellmér
    M. Boschmann
    M. B. Monroe
    A. R. Shuldiner
    E. Ravussin
    Diabetologia, 1997, 40 : 838 - 842
  • [2] Trp64Arg variant of the β3-adrenoceptor and insulin resistance in obese postmenopausal women
    García-Rubi, E
    Starling, RD
    Tchernof, A
    Matthews, DE
    Walston, JD
    Shuldiner, AR
    Silver, K
    Poehlman, ET
    Calles-Escandón, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (11): : 4002 - 4005
  • [3] The Trp64Arg of β3-adrenoceptor gene and food intake in young healthy female
    Sakane, Naoki
    Hamada, Taku
    Kotani, Kazuhiko
    Higasi, Akane
    Matsubara, Chikanobu
    OBESITY RESEARCH & CLINICAL PRACTICE, 2007, 1 (04) : 289 - 290
  • [4] Trp64Arg mutation of β3-adrenoceptor gene deteriorates lipolysis induced by β3-adrenoceptor agonist in human omental adipocytes
    Umekawa, T
    Yoshida, T
    Sakane, N
    Kogure, A
    Kondo, M
    Honjyo, H
    DIABETES, 1999, 48 (01) : 117 - 120
  • [5] Lipid metabolism and the Trp64Arg beta(3)-adrenergic receptor mutation in Pima Indians.
    Tataranni, PA
    Shuldiner, AR
    Ravussin, E
    DIABETES, 1996, 45 : 328 - 328
  • [6] Trp64Arg mutation of β3-adrenoceptor gene is associated with diabetic nephropathy in Type II diabetes mellitus
    Sakane, N
    Yoshida, T
    Yoshioka, K
    Nakamura, Y
    Umekawa, T
    Kogure, A
    Takakura, Y
    Kondo, M
    DIABETOLOGIA, 1998, 41 (12) : 1533 - 1534
  • [7] Trp64Arg β3-adrenoceptor:: When does a candidate gene become a disease-susceptibility gene?
    Shuldiner, AR
    Sabra, M
    OBESITY RESEARCH, 2001, 9 (12): : 806 - 809
  • [8] The relationship between the Trp 64 Arg polymorphism of the beta 3-adrenoceptor gene and idiopathic overactive bladder
    Ferreira, Cristina E.
    Fonseca, Andrea M.
    Silva, Ismael D.
    Girao, Manoel J.
    Sartori, Marair G.
    Castro, Rodrigo A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 205 (01) : 82.e10 - 82.e14
  • [9] No effect of the Trp64Arg β3-adrenoceptor gene variant on weight loss, body composition, or energy expenditure in obese, caucasian postmenopausal women
    Rawson, ES
    Nolan, A
    Silver, K
    Shuldiner, AR
    Poehlman, ET
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (06): : 801 - 805
  • [10] No effect of the Trp64Arg beta(3)-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue
    Snitker, S
    Odeleye, OE
    Hellmer, J
    Boschmann, M
    Monroe, MB
    Shuldiner, AR
    DIABETOLOGIA, 1997, 40 (07) : 838 - 842